{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Link Pharma Chem Ltd Valuation Shifts Amidst Challenging Market Conditions
Link Pharma Chem Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite ongoing challenges in profitability and market performance. This recalibration in price attractiveness comes amid a backdrop of subdued returns relative to the broader Sensex and a deteriorating financial quality profile, prompting a reassessment of its investment appeal within the commodity chemicals sector.
Link Pharma Chem Ltd Falls to 52-Week Low of Rs.23.5 Amidst Continued Underperformance
Link Pharma Chem Ltd’s stock touched a fresh 52-week low of Rs.23.5 today, marking a significant decline amid ongoing challenges in the commodity chemicals sector. The stock’s performance continues to lag behind key benchmarks, reflecting persistent pressures on the company’s financial metrics and market positioning.
Link Pharma Chem Ltd Valuation Shifts to Attractive Amid Mixed Market Returns
Link Pharma Chem Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a nuanced change in price attractiveness despite ongoing operational challenges. This article analyses the company’s current valuation metrics in comparison with its historical averages and peer group, providing investors with a comprehensive view of its market positioning as of February 2026.
Link Pharma Chem Ltd Falls 3.20%: 2 Key Factors Driving the Weekly Decline
Link Pharma Chem Ltd’s stock declined by 3.20% over the week ending 20 February 2026, closing at Rs.29.03 against a 0.39% gain in the Sensex. Despite a positive financial turnaround reported midweek and a shift to a more attractive valuation, the stock faced selling pressure amid mixed market sentiment and operational challenges.
Link Pharma Chem Ltd Valuation Shifts to Very Attractive Amid Mixed Market Performance
Link Pharma Chem Ltd, a player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from a risky to a very attractive valuation grade. Despite a challenging market backdrop and mixed returns relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a compelling investment case for value-focused investors.
Link Pharma Chem Ltd Reports Positive Financial Turnaround in Q4 2025
Link Pharma Chem Ltd, a player in the commodity chemicals sector, has demonstrated a notable improvement in its financial performance for the quarter ended December 2025. The company’s financial trend has shifted from flat to positive, reflecting growth in net sales, profitability, and operating margins, despite persistent challenges in receivables management and a subdued stock performance relative to broader market indices.
Are Link Pharma Chem Ltd latest results good or bad?
Link Pharma Chem Ltd's latest Q2 FY26 results are concerning, showing a 19.46% decline in net sales quarter-on-quarter and a 95% drop in net profit, indicating significant operational challenges and margin erosion despite year-on-year revenue growth. The company needs to improve profitability and cost management to address these issues.
Link Pharma Chem Ltd Falls to 52-Week Low of Rs.28 Amidst Continued Downtrend
Link Pharma Chem Ltd has touched a fresh 52-week low of Rs.28 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has underperformed its sector and benchmark indices, reflecting persistent pressures on its financial performance and valuation metrics.
Link Pharma Chem Ltd is Rated Strong Sell
Link Pharma Chem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Why is Link Pharma Chem falling/rising?
On 19 Dec, Link Pharma Chem Ltd witnessed a significant price rise of 9.33%, closing at ₹32.80, marking a notable rebound after two days of consecutive declines and outperforming its sector peers.
Link Pharma Chem Sees Revision in Market Assessment Amidst Challenging Fundamentals
Link Pharma Chem has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. The reassessment highlights concerns across quality, valuation, financial trends, and technical indicators, underscoring the pressures faced by this microcap player in the commodity chemicals sector.
Why is Link Pharma Chem falling/rising?
As of 14-Nov, Link Pharma Chem Ltd's stock price is Rs 34.95, up 4.14% today but down 14.76% year-to-date. Despite a short-term gain, the stock's long-term performance is weak compared to the broader market, indicating potential challenges ahead.
Link Pharma Chem Q2 FY26: Profitability Collapses Amid Margin Erosion and Volume Decline
Link Pharma Chem Ltd., a micro-cap chemical manufacturer with a market capitalisation of ₹15.52 crores, reported deeply disappointing results for Q2 FY26, with net profit plummeting 95.00% quarter-on-quarter to just ₹0.02 crores from ₹0.40 crores in Q1 FY26. The company, which manufactures thionyl chloride and operates in the commodity chemicals segment, saw its profitability evaporate despite posting a marginal year-on-year revenue improvement of 31.04% to ₹6.29 crores.
How has been the historical performance of Link Pharma Chem?
Link Pharma Chem has experienced a significant decline in net sales and profitability, with losses reported in the most recent fiscal year. Net sales dropped from 53.56 Cr in March 2022 to 25.43 Cr in March 2025, and the company reported a profit after tax loss of -1.03 Cr in March 2025.
When is the next results date for Link Pharma Chem?
Link Pharma Chem will announce its results on 13 November 2025.
Why is Link Pharma Chem falling/rising?
As of 07-Nov, Link Pharma Chem Ltd's stock price is Rs 32.61, down 6.72%, significantly underperforming its sector and the broader market. The stock has shown high volatility and decreased investor participation, with notable declines over the past week, month, and year.
Why is Link Pharma Chem falling/rising?
As of 07-Oct, Link Pharma Chem Ltd is priced at 35.00, having increased by 0.75%. The stock has shown erratic trading patterns and is currently underperforming compared to the Sensex, with a 4.53% decline over the past week and a year-to-date drop of 14.63%.
Why is Link Pharma Chem falling/rising?
As of 01-Oct, Link Pharma Chem Ltd is currently priced at 37.00, showing a short-term gain of 0.93% but a year-to-date decline of 9.76%. Despite recent positive trends, the stock's long-term performance is under pressure compared to the broader market.
Why is Link Pharma Chem falling/rising?
As of 29-Sep, Link Pharma Chem Ltd's stock price is Rs 35.00, down 6.57%, with significant underperformance compared to its sector and a bearish trend indicated by trading below all major moving averages. The stock has seen a drastic drop in delivery volume and has underperformed the Sensex year-to-date, despite a recent month of relative outperformance.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
